Bentong L. Yu
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: July 08, 2026
Extracellular vesicles derived from cancer-associated fibroblasts facilitate NSCLC progression and metastasis via miR-664b-5p-mediated activation of the CXCL12/CXCR4 chemokine pathway.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: March 12, 2026
A pan-cancer single-cell atlas uncovers the role of sex hormones and chromosomes in sex-divergent reprogramming of the tumor microenvironment.
Journal: Cell communication and signaling : CCS
Published: January 10, 2026
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in China.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: November 04, 2025
Pathologic complete response after neoadjuvant immunochemotherapy: Persistent recurrence risk highlights the need for stratified management.
Journal: The Journal of thoracic and cardiovascular surgery
Published: November 04, 2025
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial.
Journal: The lancet. Gastroenterology & hepatology
Published: October 24, 2025
SIRT5-mediated FDX1 desuccinylation confers cuproptosis resistance in lung adenocarcinoma.
Journal: Cell reports
Published: September 29, 2025
TLR4 promotes ESCC progression by driving inflammation and metabolic reprogramming through SLC39A10-mediated zinc homeostasis.
Journal: Journal of translational medicine
Published: September 28, 2025
CoreFormer high fidelity pulmonary nodule segmentation with structural core priors and geodesic implicit fields.
Journal: NPJ digital medicine
Published: September 06, 2025
Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
Journal: Signal transduction and targeted therapy
Published: July 25, 2025
Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2).
Journal: Signal transduction and targeted therapy
Published: May 29, 2025
Survival effect of PET/CT-defined occult lymph node metastasis in the newly proposed ninth edition N descriptors: a multicentre study.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 20, 2025
Last Updated: 09/26/2026